BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34169227)

  • 1. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.
    Kelkar S; Oyekunle T; Eisenberg A; Howard L; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen Z; Terris MK; Freedland SJ; Csizmadi I
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34169227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, race, and long-term prostate cancer outcomes.
    Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
    Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Vidal AC; Howard LE; Sun SX; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):72-78. PubMed ID: 27698439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
    Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ
    BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort.
    Liu IT; Gu L; De Hoedt AM; Cooperberg MR; Amling CL; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Vidal AC; Aronson WJ; Freedland SJ; Csizmadi I
    Cancer Causes Control; 2023 Nov; 34(11):983-993. PubMed ID: 37405681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Vidal AC; Howard LE; de Hoedt A; Kane CJ; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Freedland SJ
    BJU Int; 2018 Jul; 122(1):76-82. PubMed ID: 29521009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH.
    Griffin K; Csizmadi I; Howard LE; Pomann GM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Beebe-Dimmer J; Freedland SJ
    Cancer Causes Control; 2019 Mar; 30(3):259-269. PubMed ID: 30701374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer.
    Miller ET; Chamie K; Kwan L; Lewis MS; Knudsen BS; Garraway IP
    Cancer Med; 2017 Jan; 6(1):163-172. PubMed ID: 27997745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study.
    Barlow SK; Oyekunle T; Janes JL; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen ZW; Terris MK; Freedland SJ; Csizmadi I
    Prostate; 2022 Feb; 82(3):366-372. PubMed ID: 34905632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer.
    Howard LE; Moreira DM; De Hoedt A; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ
    BJU Int; 2017 Nov; 120(5B):E80-E86. PubMed ID: 28371163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.
    Nik-Ahd F; Howard LE; Eisenberg AT; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
    Cancer; 2019 Aug; 125(16):2861-2867. PubMed ID: 31034601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort.
    Sergeyev A; Gu L; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Freedland SJ; Csizmadi I
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1208-1216. PubMed ID: 37294698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
    Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
    Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.
    Yirga A; Oyekunle T; Howard LE; De Hoedt AM; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Taioli E; Fowke JH; Klaanssen Z; Freedland SJ; Vidal AC
    Cancer Causes Control; 2021 Feb; 32(2):189-197. PubMed ID: 33392907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of surgical margin status on prostate-cancer-specific mortality.
    Chalfin HJ; Dinizo M; Trock BJ; Feng Z; Partin AW; Walsh PC; Humphreys E; Han M
    BJU Int; 2012 Dec; 110(11):1684-9. PubMed ID: 22788795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
    Wu C; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2013 Jun; 111(8):E310-8. PubMed ID: 23305170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
    Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.
    Jayachandran J; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):9-17. PubMed ID: 20056618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.